Source Natural Foods and Herbal Supplements Ltd.
Snapshot View

181.00 +1.60 ▲0.9%

03 October 2022, 01:04:00 PM
Volume: 2,205

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.source_natural.com
Market Cap 112.00 Cr.
Enterprise Value(EV) 114.65 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 3.34 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 52.05 Trailing Twelve Months Ending 2022-06
Industry PE 31.52 Trailing Twelve Months Ending 2022-06
Book Value / Share 24.96 Trailing Twelve Months Ending 2022-06
Price to Book Value 6.97 Calculated using Price: 174.00
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 0.64 Cr. 6,436,931 Shares
FaceValue 10
Company Profile
Inwinex Pharmaceuticals, incorporated in 1995, is engaged in the manufacture of pharmaceuticals. Earlier known as Inwinex Laboratories, it got its present name on March 2, 2007.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
+0.89%
1 Week
+4.62%
1 Month
+14.05%
3 Month
+103.37%
6 Month
+83.29%
1 Year
+31.25%
2 Year
+50.08%
5 Year
+31.54%
10 Year
+741.86%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 16.04 5.86 3.86 8.31 22.42 10.87 12.40 17.65 29.40
Return on Capital Employed (%) 8.19 3.56 3.22 8.94 20.40 11.67 13.56 20.89 33.55
Return on Assets (%) 7.53 3.30 2.75 6.76 15.73 7.31 9.84 14.60 24.11

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 2 5 5 6 7 8 9 10 13 16
Non Curr. Liab. 2 0 0 0 0 0 0 0 -1 0
Curr. Liab. 0 0 1 1 4 3 2 3 4 3
Minority Int.
Equity & Liab. 5 6 6 7 11 11 10 12 16 19
Non Curr. Assets 4 4 4 3 4 4 4 4 5 7
Curr. Assets 1 2 2 3 8 7 6 9 11 12
Misc. Exp. not W/O
Total Assets 5 6 6 7 11 11 10 12 16 19

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 4 5 7 11 16 11 13 14 25 18
Other Income 0 0 0 0 0 0 0 0
Total Income 4 5 7 11 16 11 13 14 25 19
Total Expenditure -3 -4 -6 -10 -14 -9 -11 -11 -21 -15
PBIDT 1 0 1 1 2 1 2 2 5 3
Interest 0 0 0 0 0 0 0 0
Depreciation 0 0 -1 0 0 0 0 0 0 0
Taxation 0 0 0 0 0 -1 -1
Exceptional Items 0 0
PAT 0 0 0 0 1 1 1 2 3 2
Adjusted EPS 1 0 0 1 2 1 2 3 5 3

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 0 0 0 0 -1 0 3 0 4
Cash Fr. Inv. 0 0 -1 0 0 -2 0 0 -1 -2
Cash Fr. Finan. 1 0 0 0 0 2 0 -2 0 0
Net Change 0 0 0 0 0 -1 0 1 -1 3
Cash & Cash Eqvt 0 1 0 1 1 0 0 1 0 3

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 74.37 74.37 74.37 74.37 74.37 74.37 74.37 74.37 74.37
Public 25.63 25.63 25.63 25.63 25.63 25.63 25.63 25.63 25.63
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Tue, 27 Sep 2022
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith the voting results in the prescribed format in respect of the votes cast through remote e-voting and e-voting at the 27th AGM. A copy of the Scrutinizers Report containing consolidated voting results is enclosed herewith.
Tue, 27 Sep 2022
Announcement Under Regulation 30
This is to inform that based on the recommendation of Nomination and Remuneration Committee and the Board of Directors the shareholders of the Company at their 27th Annual General Meeting held on 26th September 2022 had approved by way of the re- appointment of Mr. Tejagna Kashmira Katpitia as Whole-Time Director of the Company for further term of five years DIN 00445283.Pursuant to the SEBI Circular CIR/CFD/CMD/4/2015 dated September 9 2015 their brief profile is enclosed herewith.
Tue, 27 Sep 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 the Company has received the intimation from our RTA - M/s. Venture Capital and Corporate Investment Private Limited regarding the duplicate share certificates of the Company that have been issued

Technical Scans View Details >>

Fri, 30 Sep 2022
Close Crossing Last Week High Close Crossing Last Week High
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase 1 Month High Increase 1 Month
High Increase 3 Months High Increase 3 Months
High Increase 6 Months High Increase 6 Months

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 227,696.89 960.25 +1.2%
Divi's Laboratories Ltd. 97,811.90 3,792.00 +2.3%
Cipla Ltd. 89,996.82 1,143.00 +2.5%
Dr. Reddy's Laboratories Ltd. 72,145.56 4,410.00 +1.7%
Apollo Hospitals Enterprise Ltd. 62,833.90 4,423.00 +0.9%
Torrent Pharmaceuticals Ltd. 52,506.43 1,586.70 +1.7%
Abbott India Ltd. 40,438.70 18,950.00 -1.0%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 58.54 960.25 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 31.50 3,792.00 +2.3%
Cipla Ltd. Consolidated 2022-06 36.17 1,143.00 +2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 24.12 4,410.00 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 71.12 4,423.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 65.55 1,586.70 +1.7%
Abbott India Ltd. Standalone 2022-06 50.01 18,950.00 -1.0%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.54 960.25 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-06 7.87 3,792.00 +2.3%
Cipla Ltd. Consolidated 2022-06 4.19 1,143.00 +2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.56 4,410.00 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.57 4,423.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.21 1,586.70 +1.7%
Abbott India Ltd. Standalone 2022-06 13.56 18,950.00 -1.0%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 960.25 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,792.00 +2.3%
Cipla Ltd. Consolidated 2022-03 0.04 1,143.00 +2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,410.00 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,423.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,586.70 +1.7%
Abbott India Ltd. Standalone 2022-03 0.00 18,950.00 -1.0%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 960.25 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,792.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,143.00 +2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,410.00 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,423.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,586.70 +1.7%
Abbott India Ltd. Standalone 2022-03 29.95 18,950.00 -1.0%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 960.25 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,792.00 +2.3%
Cipla Ltd. Consolidated 2022-03 13.10 1,143.00 +2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,410.00 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,423.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,586.70 +1.7%
Abbott India Ltd. Standalone 2022-03 29.95 18,950.00 -1.0%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 960.25 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,792.00 +2.3%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,143.00 +2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,410.00 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,423.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,586.70 +1.7%
Abbott India Ltd. Standalone 2022-03 4,919.27 18,950.00 -1.0%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 960.25 +1.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,792.00 +2.3%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,143.00 +2.5%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,410.00 +1.7%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,423.00 +0.9%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,586.70 +1.7%
Abbott India Ltd. Standalone 2022-03 798.70 18,950.00 -1.0%

FAQ's On Source Natural Foods and Herbal Supplements Ltd.

What is Source Natural Foods share price?

Can I buy Source Natural Foods shares now?

What is the Market Cap of Source Natural Foods?

What are the key metrics to analyse Source Natural Foods?

What is the 52 Week High and Low of Source Natural Foods?

What is the trend of Source Natural Foods share price?